IL-19 Antibody (RN19) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-00394
Key Product Details
Species Reactivity
Validated:
Mouse
Applications
ELISA
Label
Unconjugated
Antibody Source
Monoclonal Rat IgG1 kappa Clone # RN19
Format
BSA Free
Concentration
0.5 mg/ml
Product Summary for IL-19 Antibody (RN19) - BSA Free
Immunogen
The immunogen for this antibody is IL-19 (RN19).
Reactivity Notes
Mouse
Clonality
Monoclonal
Host
Rat
Isotype
IgG1 kappa
Scientific Data Images for IL-19 Antibody (RN19) - BSA Free
ELISA: IL-19 Antibody (RN19) - BSA Free [NBP2-00394]
ELISA: IL19 Antibody (RN19) [NBP2-00394] - Standard curve of mouse IL-19.Applications for IL-19 Antibody (RN19) - BSA Free
Application
Recommended Usage
ELISA
1:100-1:2000
Application Notes
The RN19 antibody has been tested as the capture antibody in a sandwich ELISA for analysis of mouse Interleukin-19 (IL-19) in combination with the Biotin polyclonal antibody for detection. A suitable range of concentrations of this antibody for ELISA capture is 1.0-4 ug/ml. A standard curve consisting of doubling dilutions of the recombinant standard over the range of 4000 pg/ml - 30 pg/ml should be included in each ELISA plate.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2)
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: IL-19
Long Name
Interleukin 19
Alternate Names
IL19
Gene Symbol
IL19
Additional IL-19 Products
Product Documents for IL-19 Antibody (RN19) - BSA Free
Product Specific Notices for IL-19 Antibody (RN19) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...